#lupin

[lwonderlnd]

Arsène Lupin - Sherlock, Lupin & Me

[lunathejediknight]

omg I love designing lupins and their different tribal outfits, it's so much fun!

I love designing and doing lore stuff for the lupins omg

[getinjigenwitit]

RIP Yukiko Nikaido (1940 - 2026). Fujiko's Part I voice actor, with her passing, there are no more surviving members of the original 1971 main cast. May she rest in peace ❤️🙏

[vvintrkid]

okay another more general lupin thing i like.

i like the dedication to ideas that are just so stupid but they’ll run them anyway bc heists every episode necessitate new and entertaining action sequences. this either falls into: weirdly contrived and complicated heist-plans OR. weirdly contrived and complicated contraptions (my favorite)

bonus: this “yahoo” is the most excited we see jigen in like 50 eps. it goes in the folder & id be this excited too if this actually worked

[sideburns-and-cigarettes]

NEW EPISODE: Part II, Ep. 8: "Venetian Super Express" (or "Disorient Express")

It's burglary on the Orient Express! Our journey across The Top 50(ish) Episodes of Lupin III: Part II (according to the hosts and listeners of Sideburns & Cigarettes) continues! Join us as we discuss the horsepower, horseplay, and horse(!!) of Part II, Episode 8: “Venetian Super Express” (or “Disorient Express”)

You can listen on SoundCloud, Apple Podcasts, Spotify, and Podbean!

[healthconscious123]

A Positive Step Forward for Children Living with Rare Neuromuscular Disorders 💙

Big news in the world of rare disease treatment!

Lupin Limited has announced that the European Medicines Agency (EMA) has approved an expanded indication for NaMuscla® (mexiletine), making the treatment available for pediatric patients while also introducing two new capsule strengths.

For families affected by non-dystrophic myotonic disorders (NDM), this represents a meaningful step toward improving access to care.

What Has Changed?

The updated EMA approval now includes:

✔ Children aged 6–11 years weighing at least 20 kg

✔ Adolescents aged 12–17 years

✔ Adults aged 18 years and above

Alongside the existing 167 mg capsule, two new strengths—62 mg and 83 mg—have also been approved to support age-appropriate treatment.

Why Is This Important?

Non-dystrophic myotonic disorders are rare inherited conditions that affect muscle relaxation. Everyday actions like walking, climbing stairs, or even releasing a handshake can become difficult because muscles remain contracted longer than normal.

Since symptoms often begin during childhood, having treatment options designed for younger patients can make a real difference in long-term disease management and quality of life.

Lupin's Continued Focus on Innovation

Lupin continues to expand its work in specialty medicines and rare diseases, helping improve access to therapies across global markets.

The company has stated that the newly approved strengths and expanded indication will become available across Europe according to country-specific implementation and reimbursement timelines.

If you'd like to read the official announcement, visit:

👉 https://www.lupin.com/US/media/lupin-announces-ema-approval-for-na-muscla-expansion-for-pediatric-indication-with-new-strengths

You can also learn more about Lupin and its global healthcare initiatives at:

🌐 https://www.lupin.com/US/

Every advancement in rare disease treatment matters. Expanding access for children is another reminder of how research, regulatory progress, and innovation continue to improve healthcare for patients around the world.

[vvintrkid]

do u think whenever goemons not around for this stuff jigen is secretly like “yesss. jigen time” before pulling some absolute bullshit